Abstract
Background:Bi-specific T-cell engagers (BiTEs) kill B cells by engaging T cells. BITEs are highly effective in acute lymphoblastic leukemia but have not yet been tested in autoimmune disease. Multi-drug resistant...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have